Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/01/2010EP1451144B1 Compositions for treating acne comprising phytandiol amine
09/01/2010EP1432731B1 Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
09/01/2010EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
09/01/2010EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
09/01/2010EP1285651B1 Melanin concentrating hormone antagonists
09/01/2010EP1255543B1 Use of retinoid-type compounds as antibacterial agents against staphylococcus aureus
09/01/2010EP1207905B1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010EP0980363B9 Preparation of isoflavones from legumes
09/01/2010CN201564118U Pillow for placing auxiliary substance
09/01/2010CN1995065B Fusion protein for suppressing PTTG expression and its coding gene and uses
09/01/2010CN1989956B Adapalene gel composition and its preparation
09/01/2010CN1976906B Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
09/01/2010CN1969855B Pharmaceutical composition having target organ protection function and usage thereof
09/01/2010CN1948298B Dopamine D3 acceptor portion agonist and its application
09/01/2010CN1947794B Medicine composition containing sulfonylurea compounds and phenoxy acid type compounds
09/01/2010CN1946674B Method for the synthesis of quaternary ammonium compounds and compositions thereof
09/01/2010CN1943651B A medicinal composition for treating gout
09/01/2010CN1938018B Use of compounds for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level
09/01/2010CN1917868B Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis
09/01/2010CN1857345B Hemicrania treating medicine composition and its preparing method
09/01/2010CN1846721B Tranquilizing seven-leaf oral cavity disintegrated tablet and its preparation method
09/01/2010CN1788614B Health food and drink containing nucleic acid chitin chitosamine
09/01/2010CN1706841B 1-(4,4-diaryl-3-butene)-piperidine formic acid or its medicine salt, preparation process and application
09/01/2010CN101821392A RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
09/01/2010CN101821391A Micromirs
09/01/2010CN101821390A Oligonucleotides for modulation of target RNA activity
09/01/2010CN101821290A Influenza virus haemagglutinin-specific monoclonal antibodies
09/01/2010CN101821274A Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof
09/01/2010CN101821271A 6-substituted sulfonyl azabicyclo 3.2.1''octanes useful to inhibit 11 -hydroxysteroid dehydrogenase type-1
09/01/2010CN101821270A 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1
09/01/2010CN101821269A 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2
09/01/2010CN101821268A Tetracyclic compounds for the treatment of hepatitis c
09/01/2010CN101821267A Compounds for the treatment of hepatitis c
09/01/2010CN101821266A Modulators of cystic fibrosis transmembrane conductance regulator
09/01/2010CN101821265A Substituted bicyclic piperidinyl-and piperazinyl- sulfonamides useful to inhibit 11ss-hydroxysteroid dehydrogenase type-1
09/01/2010CN101821264A Pyridine derivatives useful as glucokinase activators
09/01/2010CN101821263A Dipeptoid prodrugs and the use thereof
09/01/2010CN101821262A Gambogic amine, selective trka agonist with neuroprotective activity
09/01/2010CN101821261A Trisubstituted piperidines
09/01/2010CN101821260A Substituted oxazolidinone derivatives
09/01/2010CN101821259A Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
09/01/2010CN101821257A 5-HT7 receptor antagonists
09/01/2010CN101821255A 2-morpholin-4-yl-pyrimidines as PI3K inhibitors
09/01/2010CN101821254A Adrenergic compounds
09/01/2010CN101821253A Piperidine derivative
09/01/2010CN101821252A Substituted indole derivatives and methods of use thereof
09/01/2010CN101821251A Chiral cis-imidazolines
09/01/2010CN101821247A 5-(2-hydroxy phenyl)tetrazole compound as hsp90 inhibitor for anticancer
09/01/2010CN101821246A Tetrazole-substituted aryl amide derivatives and uses thereof
09/01/2010CN101821243A Pyrimidinyl-propionic acid derivatives and their use as ppar agonists
09/01/2010CN101821241A Gamma secretase modulators
09/01/2010CN101821240A N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators
09/01/2010CN101821236A Five-membered heterocyclic compound
09/01/2010CN101821235A Pyrrolidin-2 -one derivatives as androgen receptor modulator
09/01/2010CN101821234A Phenoxy-pyrrolidine derivative and its use and compositions
09/01/2010CN101821229A Tricyclic amine compound
09/01/2010CN101820950A Biphenylcarboxamide derivatives as hedgehog pathway modulators
09/01/2010CN101820919A Injectable polymer-lipid blend for localized drug delivery
09/01/2010CN101820917A Aqueous ophthalmic formulations
09/01/2010CN101820916A Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators
09/01/2010CN101820914A Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient
09/01/2010CN101820909A Methods of enhancing adjuvanticity of vaccine compositions
09/01/2010CN101820897A Cytoplasmic malate dehydrogenase (MDH1) targeted treatment for neurodegenerative diseases
09/01/2010CN101820892A Treatment regime for proliferative disorders
09/01/2010CN101820887A Controlled release interferon drug products and treatment of hcv infection using sam
09/01/2010CN101820886A Bifunctional synthetic molecules
09/01/2010CN101820885A Preparation for wound healing and prevention of bandage adhesion to the wound, containing chitosan-glucan
09/01/2010CN101820884A Phenothiazine compounds for treating mild cognitive impairment
09/01/2010CN101820883A Method for inducing hepatocyte proliferation and uses thereof
09/01/2010CN101820882A Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis
09/01/2010CN101820881A Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treament of inflammation
09/01/2010CN101820880A Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
09/01/2010CN101820879A Antimalarial compounds with flexible side-chains
09/01/2010CN101820878A Tetrahydroquinoline derivatives for treating post-traumatic stress disorders
09/01/2010CN101820877A Agent for fungal dermatitis
09/01/2010CN101820876A Method for treating acute pain with formulated drug depot in combination with liquid formulation
09/01/2010CN101820875A Pharmaceutical formulations containing lipoic acid derivatives
09/01/2010CN101820874A Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue
09/01/2010CN101820873A Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
09/01/2010CN101820872A Antimicrobial agent and external preparation for skin containing the same
09/01/2010CN101820871A Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
09/01/2010CN101820870A Uses of trientine and penicillamine as countermeasures to metal contamination
09/01/2010CN101820869A Method to ameliorate oxidative stress and improve working memory via pterostilbene administration
09/01/2010CN101820868A Novel compounds as cannabinoid receptor ligands
09/01/2010CN101820867A 固体缬沙坦组合物 Solid compositions of Valsartan
09/01/2010CN101820865A Improvements relating to anti-HIV tablet formulations
09/01/2010CN101820862A Method for stabilizing phenylephrine
09/01/2010CN101820860A Topical composition
09/01/2010CN101820859A Process for the manufacure of pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate
09/01/2010CN101820838A Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms
09/01/2010CN101820765A Compositions including androgen receptor degradation (ard) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss
09/01/2010CN101820764A Therapeutic isoxazole compounds
09/01/2010CN101820762A Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
09/01/2010CN101820760A Fused heterocycles
09/01/2010CN101820758A Novel forms of cddo methyl ester
09/01/2010CN101820757A Treatment of viral infections by modulation of host cell metabolic pathways
09/01/2010CN101820755A Anti-inflammatory compounds and uses thereof
1 ... 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 ... 7860